Grants and Contributions:
Title:
Business development for customer acquisition and scaling of platform for therapists
Agreement Number:
987516
Agreement Value:
$41,520.00
Agreement Date:
Mar 1, 2022 - Oct 31, 2022
Description:
The purpose of this project is to increase the number of customers using the Divergence Neuro Platform for Therapists by increasing brand awareness, identifying key prospects and leads, communicating with and nurturing key prospect stakeholders and ultimately converting those prospects into customers of the platform.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5G 0A8
Reference Number:
172-2021-2022-Q4-987516
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
708762935
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Amendment Date
Aug 19, 2022
Recipient's Operating Name:
Divergence Neuro
Recipient's Legal Name:
Divergence Neuro Technologies Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3391
Amendments: